Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain CRL message board posts where the ticker symbol CRL has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest CRL SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-032963 Size: 8 KB
2018-11-14
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-032479 Size: 7 KB
2018-11-08
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001100682-18-000018 (34 Act)  Size: 11 MB
2018-11-07 001-15943
181165587
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001157523-18-002346 (34 Act)  Size: 326 KB
2018-11-07 001-15943
181164716
8-K  Documents Current report, item 5.02
Acc-no: 0001193125-18-291981 (34 Act)  Size: 15 KB
2018-10-03 001-15943
181105592
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-026778 Size: 38 KB
2018-09-05
8-K  Documents Current report, item 5.02
Acc-no: 0000950103-18-010309 (34 Act)  Size: 18 KB
2018-08-31 001-15943
181050550
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-025253 Size: 24 KB
2018-08-14
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-025247 Size: 4 KB
2018-08-14
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001100682-18-000012 (34 Act)  Size: 10 MB
2018-08-08 001-15943
181001924
More CRL SEC Filings


Related news from
Tue, 20 Nov 2018
11:22:49 +0000
Employees allege racial discrimination at Charles River Laboratories facility
A group of current and former Charles River Laboratories employees is suing the company, alleging that the lab services company has ignored their unequal pay and racial discrimination complaints.
Tue, 13 Nov 2018
13:00:00 +0000
Charles River Laboratories Continues Commitment to Oncology Drug Discovery
Charles River Laboratories International, Inc. (CRL) today announced new additions to the Tumor Model Compendium. Charles River’s Compendium provides access to a comprehensive collection of well-established tumor models for early-stage oncology research. The most recent Compendium update adds gastric and liver models, as well as new molecular data for leukemia, liver cancer, lymphoma, breast cancer and ovarian cancer.
Sat, 10 Nov 2018
18:46:38 +0000
Edited Transcript of CRL earnings conference call or presentation 7-Nov-18 1:30pm GMT
Q3 2018 Charles River Laboratories International Inc Earnings Call
Sat, 10 Nov 2018
13:04:52 +0000
See what the IHS Markit Score report has to say about Charles River Laboratories International Inc.
Charles River Laboratories International Inc NYSE:CRL
Wed, 07 Nov 2018
23:51:08 +0000
Charles River Laboratories International Inc (CRL) Q3 2018 Earnings Conference Call Transcript
CRL earnings call for the period ending September 29, 2018.
Wed, 07 Nov 2018
19:27:19 +0000
Charles River Laboratories International Inc (NYSE:CRL): Will The Growth Last?
Looking at Charles River Laboratories International Inc’s (NYSE:CRL) earnings update in June 2018, it seems that analyst forecasts are substantially optimistic, with profits predicted to ramp up by an impressive<div><a class="permalink" href="https://simplywall.st/news/yahoo-post/charles-river-laboratories-international-inc-nysecrl-will-the-growth-last/">Read More...</a></div>
Wed, 07 Nov 2018
13:25:01 +0000
Charles River Laboratories (CRL) Q3 Earnings and Revenues Top Estimates
Charles River (CRL) delivered earnings and revenue surprises of 10.87% and 3.12%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Wed, 07 Nov 2018
12:21:19 +0000
Charles River: 3Q Earnings Snapshot
The Wilmington, Massachusetts-based company said it had net income of $1.22 per share. Earnings, adjusted for one-time gains and costs, were $1.53 per share. The results surpassed Wall Street expectations. ...
Wed, 07 Nov 2018
12:00:00 +0000
Charles River Laboratories Announces Third-Quarter 2018 Results
– Third-Quarter Revenue of $585.3 Million –
Tue, 30 Oct 2018
12:00:00 +0000
Charles River to Present Collaborative Methods at Neuroscience 2018
Charles River Laboratories International, Inc. (CRL) today announced that its team of neuroscience drug discovery experts will present 26 scientific posters, both independently and collaboratively with clients, at Neuroscience 2018, the 48th annual meeting of the Society for Neuroscience (SfN). Throughout the conference, Charles River experts will be presenting posters and hosting discussions on the latest innovations in neuroscience research, including innovative tools and applications for research on drugs targeting Huntington’s, Alzheimer’s, Parkinson’s, Multiple Sclerosis, and other neurological disorders.
Mon, 29 Oct 2018
12:25:00 +0000
Market Trends Toward New Normal in Polaris Industries, NIKE, Charles River Laboratories International, Actuant, Caesarstone, and Enzo Biochem — Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, Oct. 29, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Thu, 25 Oct 2018
12:00:00 +0000
Charles River and Distributed Bio Enter Exclusive Partnership to Create an Integrated Antibody Discovery and Development Platform
New partnership allows Charles River’s clients access to Distributed Bio’s antibody discovery platforms
Tue, 16 Oct 2018
12:00:00 +0000
Charles River Laboratories Awarded Five-Year, $95.7 Million Contract by the National Institute of Allergy and Infectious Diseases
Charles River Laboratories International, Inc. (CRL) today announced that it was awarded a five-year, $95.7 million contract by the National Institute of Allergy and Infectious Diseases (NIAID), which is one of the largest institutes of the National Institutes of Health (NIH). Under NIAID’s Division of Intramural Research animal care program, Charles River will manage and provide staffing for NIAID’s on-site vivarium and related research model operations. The program is required to ensure the humane care and use of research models, and the efficient management of NIAID’s research model operations.
Wed, 10 Oct 2018
20:30:00 +0000
Charles River Laboratories Schedules Third-Quarter 2018 Earnings Release and Conference Call
Charles River Laboratories International, Inc. will release third-quarter 2018 financial results on Wednesday, November 7th, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, November 7th, at 8:30 a.m.
Tue, 02 Oct 2018
20:53:46 +0000
Cancer center CEO leaves Merck board after disclosure scandal
The New York Times previously reported Thompson's resignation from Merck and from lab services company Charles River Laboratories International Inc. The move follows the resignation of Sloan Kettering's chief medical officer, Jose Baselga, in September, after a New York Times and Pro Publica investigation revealed that he had not disclosed millions of dollars in payments from health-care companies in many of his research articles.
Tue, 18 Sep 2018
14:42:10 +0000
Edited Transcript of CRL earnings conference call or presentation 8-Aug-18 12:30pm GMT
Q2 2018 Charles River Laboratories International Inc Earnings Call
Mon, 10 Sep 2018
17:08:20 +0000
Why Charles River Laboratories International Inc’s (NYSE:CRL) ROE Of 10.8% Does Not Tell The Whole Story
This article is intended for those of you who are at the beginning of your investing journey and want to learn about Return on Equity using a real-life example. CharlesRead More...
Thu, 30 Aug 2018
20:37:00 +0000
Charles River Laboratories to Present at September Investor Conferences
Charles River Laboratories International, Inc. announced today that it will present at three upcoming investor conferences, including:



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "I have been a VF subscriber for one year and have found the members here generally to be informed, intelligent, articulate people of good will. The knowledge I've gathered has been well worth the price of tuition, and the subscription fee has been repaid many-fold in investment gains." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards